Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The effect of the myo-inositol 1,4,5-trisphosphate (IP3) analogue, myo-inositol 1,4,5-trisphosphorothioate (IPS3) on the dephosphorylation of D-5-[32P]IP3 by the 5-phosphatase from human erythrocyte membranes has been investigated. DL-IPS3 was found to act as a competitive inhibitor with a Ki of 6 microM, making it the most potent inhibitor currently available for this enzyme. L-IP3 inhibited the enzyme with a Ki of 124 microM and was more potent than D-2,3-diphosphoglycerate (Ki 978 microM).

More information Original publication

DOI

10.1016/0014-5793(89)80504-6

Type

Journal article

Publication Date

1989-01-02T00:00:00+00:00

Volume

242

Pages

373 - 377

Total pages

4

Keywords

Erythrocytes, Humans, In Vitro Techniques, Inositol, Inositol 1,4,5-Trisphosphate, Inositol Polyphosphate 5-Phosphatases, Kinetics, Organothiophosphorus Compounds, Phosphoric Monoester Hydrolases